Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.56 |
| ▸ | SLC1A2 | P43004 | 7/20 | 0.50 |
| ▸ | SLC1A1 | P43005 | 7/20 | 0.50 |
| ▸ | SLC1A3 | P43003 | 6/20 | 0.50 |
| ▸ | GRIK1 | P39086 | 8/20 | 0.43 |
| ▸ | GRIK2 | Q13002 | 5/20 | 0.43 |
| ▸ | GRIA2 | P42262 | 2/20 | 0.40 |
| ▸ | GRIA4 | P48058 | 2/20 | 0.40 |
| ▸ | GRIK3 | Q13003 | 2/20 | 0.40 |
| ▸ | GRIK5 | Q16478 | 2/20 | 0.40 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3623646 | 1.00 | SLC7A5 (0.56) | SLC7A5SLC1A2SLC1A1SLC1A3GRIK1 | |
| Hydrochloric Acid SCHEMBL21518209 | 0.98 | SLC7A5 (0.54) | SLC7A5SLC1A2SLC1A1SLC1A3GRIK1 | |
| SCHEMBL21578343 | 0.82 | SLC7A5 (0.55) | SLC7A5SLC1A2SLC1A1SLC1A3GRIK1 | |
| SCHEMBL19951652 | 0.82 | SLC7A5 (0.54) | SLC7A5SLC1A2SLC1A1SLC1A3GRIK1 | |
| SCHEMBL18762560 | 0.82 | SLC7A5 (0.54) | SLC7A5SLC1A2SLC1A1SLC1A3GRIK1 | |
| Leucine SCHEMBL9119565 | 0.82 | SLC7A5 (0.72) | SLC7A5SLC1A2SLC1A1SLC1A3GRIK1 | |
| SCHEMBL197139 | 0.80 | SLC7A5 (0.48) | SLC7A5SLC1A2SLC1A1SLC1A3GRIK1 | |
| SCHEMBL196695 | 0.80 | SLC7A5 (0.48) | SLC7A5SLC1A2SLC1A1SLC1A3GRIK1 | |
| SCHEMBL197117 | 0.80 | SLC7A5 (0.48) | SLC7A5SLC1A2SLC1A1SLC1A3GRIK1 | |
| Hydrochloric Acid SCHEMBL21059082 | 0.78 | SLC7A5 (0.46) | SLC7A5SLC1A2SLC1A1SLC1A3GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0025199-B1 | CEPHEM COMPOUNDS, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1984-10-31 | — | — | EP | claimed |
| CN-118388585-A | Preparation method of amide and ester compounds based on visible light catalysis | 泰山学院 | 2024-07-26 | — | — | CN | disclosed |
| CN-118215474-A | Methods and compositions for weight management | 爱医谷(苏州)生物科技有限公司 | 2024-06-18 | — | — | CN | disclosed |
| CN-113024637-B | Method for preparing carfilzomib by taking water-soluble alkynylamide as condensing agent | 江西师范大学 | 2023-05-16 | — | — | CN | disclosed |
| CN-115806570-A | Novel peptide-like derivative, and pharmaceutical composition and application thereof | 知和(山东)大药厂有限公司 | 2023-03-17 | — | — | CN | disclosed |
| CN-113274507-A | Preparation and use of immunostimulatory conjugate complexes for targeted delivery and activation | 亚飞（上海）生物医药科技有限公司 | 2021-08-20 | — | — | CN | disclosed |
| CN-106344930-B | Preparation and application of molecular site-specific targeting and activating short peptide adriamycin | 亚飞（上海）生物医药科技有限公司 | 2021-08-17 | — | — | CN | disclosed |
| WO-2009039361-A2 | PROCESS FOR THE PREPARATION OF (S)-2-(3-TERT-BUTYLUREIDO)-3,3-DIMETHYLBUTANOIC ACID | VIROBAY, INC. (US) | 2009-03-26 | — | — | WO | disclosed |